Information:
Error:
ID
32705
Description
Study ID: 107038 Clinical Study ID: LPL107038 Study Title: Study to Estimate the Dose Proportionality of the Enteric-Coated Freebase Formulation of SB-480848 Patient Level Data: Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 1 Study Recruitment Status: Completed Generic Name: darapladib Trade Name: Tyrisa ,US Study Indication: Atherosclerosis
Keywords
Versions (1)
- 11/13/18 11/13/18 -
Copyright Holder
GSK group of companies
Uploaded on
November 13, 2018
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Estimation of Dose Proportionality of Darapladib - 107038
Follow-Up: Pregnancy Information
- StudyEvent: ODM
Similar models
Follow-Up: Pregnancy Information
- StudyEvent: ODM
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Did the subject become pregnant during the study?
Item
Did the subject become pregnant during the study?
boolean
Item
Did a female partner of the male subject become pregnant during the study?
text
Code List
Did a female partner of the male subject become pregnant during the study?
CL Item
Yes (1)
CL Item
No (2)
CL Item
Not Applicable (check if female partner not a childbearing potential or no female partner) (3)